1. Home
  2. NKTX vs SPAI Comparison

NKTX vs SPAI Comparison

Compare NKTX & SPAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nkarta Inc.

NKTX

Nkarta Inc.

HOLD

Current Price

$1.81

Market Cap

147.7M

Sector

Health Care

ML Signal

HOLD

Logo Safe Pro Group Inc. Common Stock

SPAI

Safe Pro Group Inc. Common Stock

HOLD

Current Price

$4.84

Market Cap

139.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NKTX
SPAI
Founded
2015
2021
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Industrial Specialties
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
147.7M
139.4M
IPO Year
2020
2024

Fundamental Metrics

Financial Performance
Metric
NKTX
SPAI
Price
$1.81
$4.84
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
3
Target Price
$13.25
$10.00
AVG Volume (30 Days)
684.9K
208.4K
Earning Date
11-10-2025
11-14-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$1,266,756.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$538.54
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.31
$1.47
52 Week High
$3.16
$9.16

Technical Indicators

Market Signals
Indicator
NKTX
SPAI
Relative Strength Index (RSI) 40.37 42.83
Support Level $1.77 $4.03
Resistance Level $1.93 $5.14
Average True Range (ATR) 0.09 0.42
MACD 0.01 0.09
Stochastic Oscillator 30.00 65.62

Price Performance

Historical Comparison
NKTX
SPAI

About NKTX Nkarta Inc.

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The Company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

About SPAI Safe Pro Group Inc. Common Stock

Safe Pro Group Inc operates to acquire security and protection products. Its emphasis is on the development of a cloud-based ecosystem for analyzing drone imagery and data utilizing proprietary artificial intelligence (AI), machine learning, deep learning, and applied computer vision software for hyper-scalable processing, analysis, and reporting. The company operated in three reportable business segments which consisted of: the business of Safe-Pro USA, the business of Airborne Response, and the business of Safe Pro AI. Key revenue is generated from Airborne Response.

Share on Social Networks: